Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey
Objective: The aim of the present study was to assess the efficacy and safety of tolvaptan for severe hyponatremia (SH) in hypervolemic heart failure (HF) patients within daily clinical practice. Methods: We restrospectively reviewed our database on tolvaptan as an add-on treatment in hypervolemic p...
Main Authors: | Saim Sağ, Aysel Aydin Kaderli, Abdülmecit Yildiz, Bülent Cuma Gül, Bülent Özdemir, Ibrahim Baran, Sümeyye Güllülü, Ali Aydınlar, Yüksel Çavuşoğlu |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2017-07-01
|
Series: | Türk Kardiyoloji Derneği Arşivi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-80026 |
Similar Items
-
The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia
by: Fatih Kahraman, et al.
Published: (2015-04-01) -
Review of Tolvaptan’s Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions
by: Purav R. Bhatt, et al.
Published: (2014-11-01) -
Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
by: Shuzhen Wang, et al.
Published: (2018-09-01) -
Pathophysiology of ascites and dilutional hyponatremia: Contemporary use of aquaretic agents
by: Jorge García Leiva, et al.
Published: (2007-10-01) -
Treatment of Hyponatremia with Tolvaptan in a Patient after Neurosurgical Treatment of a Pituitary Tumor: Case Report and Review of Literature
by: Shinya Ichimura, et al.
Published: (2015-10-01)